These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6260266)

  • 1. Inhibition of von Willebrand factor-dependent platelet function by increased platelet cyclic AMP and its prevention by cytoskeleton-disrupting agents.
    Coller BS
    Blood; 1981 May; 57(5):846-55. PubMed ID: 6260266
    [No Abstract]   [Full Text] [Related]  

  • 2. Identical binding site on human platelets for von Willebrand factor and bovine platelet aggregating factor.
    Suzuki K; Nishioka J; Hashimoto S
    Thromb Res; 1980 Jan 1-15; 17(1-2):215-23. PubMed ID: 6769177
    [No Abstract]   [Full Text] [Related]  

  • 3. Species specificity in von Willebrand factor-supported platelet agglutination.
    Johnson GS; Dodds WJ; Rosborough TK
    Ann N Y Acad Sci; 1981; 370():227-35. PubMed ID: 6973945
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of adenosine 3':5'-monophosphate and platelet aggregation on thromboxane biosynthesis in human platelets.
    Lindgren JA; Claesson HE; Kindahl H; Hammarström S
    FEBS Lett; 1979 Feb; 98(2):247-50. PubMed ID: 217731
    [No Abstract]   [Full Text] [Related]  

  • 5. Polybrene-induced platelet agglutination and reduction in electrophoretic mobility: enhancement by von Willebrand factor and inhibition by vancomycin.
    Coller BS
    Blood; 1980 Feb; 55(2):276-81. PubMed ID: 6766335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP metabolism in cholesterol-rich platelets.
    Sinha AK; Shattil SJ; Colman RW
    J Biol Chem; 1977 May; 252(10):3310-4. PubMed ID: 193833
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelets, von Willebrand factor, and prostaglandin I2.
    Moake JL; Tang SS; Olson JD; Troll JH; Cimo PL; Davies PJ
    Am J Physiol; 1981 Jul; 241(1):H54-9. PubMed ID: 6787937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Von Willebrand factor, polycations, and platelet agglutination.
    Rosborough TK
    Thromb Res; 1980 Feb 1-15; 17(3-4):481-90. PubMed ID: 6966084
    [No Abstract]   [Full Text] [Related]  

  • 9. Adenosine diphosphate induces binding of von Willebrand factor to human platelets.
    Fujimoto T; Hawiger J
    Nature; 1982 May; 297(5862):154-6. PubMed ID: 6281653
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitors of ADP-induced platelet aggregation prevent fibrinogen binding to rabbit platelets and cause rapid deaggregation and dissociation of bound fibrinogen.
    Harfenist EJ; Packham MA; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1981 May; 97(5):680-8. PubMed ID: 6783712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G.
    Moore A; Ross GD; Nachman RL
    J Clin Invest; 1978 Nov; 62(5):1053-60. PubMed ID: 309473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Biol Chem; 1980 Nov; 255(21):10134-9. PubMed ID: 6776109
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of agents that alter cyclic AMP on arachidonate-induced platelet aggregation in the dog.
    Johnson GJ; Rao GH; Leis LA; White JG
    Blood; 1980 May; 55(5):722-9. PubMed ID: 6244866
    [No Abstract]   [Full Text] [Related]  

  • 14. Modulation of human platelet function by prostacyclin and thromboxane A2.
    Gorman RR
    Fed Proc; 1979 Jan; 38(1):83-8. PubMed ID: 215465
    [No Abstract]   [Full Text] [Related]  

  • 15. von Willebrand factor. A protein which binds at the cell surface interface between platelets.
    Senogles SE; Nelsestuen GL
    J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Platelet adhesion and aggregation].
    David JL
    Acta Clin Belg; 1977; 32(6):363-74. PubMed ID: 211769
    [No Abstract]   [Full Text] [Related]  

  • 18. Interaction of blood platelets with a microfibrillar extract from adult bovine aorta: requirement for von Willebrand factor.
    Fauvel F; Grant ME; Legrand YJ; Souchon H; Tobelem G; Jackson DS; Caen JP
    Proc Natl Acad Sci U S A; 1983 Jan; 80(2):551-4. PubMed ID: 6601274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of succinylation and dodecyl, succinylation on bovine factor VIII/von Willebrand factor complex.
    Thuy LP; Brown JE; Baugh RF; Hougie C
    Thromb Res; 1980 May 1-15; 18(3-4):305-13. PubMed ID: 6774433
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of platelet activation on the agglutination of platelets by von Willebrand factor.
    Mills DC; Hunchak K; Karl DW; Kirby EP
    Mol Pharmacol; 1990 Feb; 37(2):271-7. PubMed ID: 2154674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.